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Abstract
Objectives Compare public perceptions and intentions to un-
dergo colorectal cancer screening tests following detailed
information regarding CT colonography (CTC; after non-
laxative preparation or full-laxative preparation), optical colo-
noscopy (OC) or flexible sigmoidoscopy (FS).
Methods A total of 3,100 invitees approaching screening age
(45-54 years) were randomly allocated to receive detailed
information on a single test and asked to return a question-
naire. Outcomes included perceptions of preparation and test
tolerability, health benefits, sensitivity and specificity, and
intention to undergo the test.
Results Six hundred three invitees responded with valid ques-
tionnaire data. Non-laxative preparation was rated more pos-
itively than enema or full-laxative preparations [effect size
(r)=0.13 to 0.54; p<0.0005 to 0.036]; both forms of CTC
and FS were rated more positively than OC in terms of test
experience (r=0.26 to 0.28; all p-values < 0.0005).
Perceptions of health benefits, sensitivity and specificity
(p=0.250 to 0.901), and intention to undergo the test (p=
0.213) did not differ between tests (n=144-155 for each test).
Conclusions Despite non-laxative CTC being rated more
favourably, this study did not find evidence that offering it
would lead to substantially higher uptake than full-laxative
CTC or other methods. However, this study was limited by a
lower than anticipated response rate.
Key Points
• Improving uptake of colorectal cancer screening tests could
improve health benefits
• Potential invitees rate CTC and flexible sigmoidoscopy more
positively than colonoscopy
• Non-laxative bowel preparation is rated better than enema
or full-laxative preparations
• These positive perceptions alone may not be sufficient to
improve uptake
• Health benefits and accuracy are rated similarly for preven-
tative screening tests
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Introduction
Several colorectal investigations are well suited to the detec-
tion of pre-malignant polyps and colorectal cancer (CRC),
including computed tomographic colonography (CTC), flex-
ible sigmoidoscopy (FS) and optical colonoscopy (OC).
Consequently, each of these modalities may be effective for
population-based screening, where asymptomatic individuals
in an age group at risk (e.g. over 50 years) are tested for
premalignant polyps that can then be removed, preventing
CRC entirely [1]. Screening can also detect pre-clinical
CRC, allowing for earlier intervention and improved
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prognosis. Uptake of CRC screening is low compared to breast
and cervical cancer [2–4] and it is intuitive that invitees would
be most likely to undergo tests that align with their preferences.
CTC has high sensitivity (the probability of detecting dis-
ease when it is present) for large (≥10 mm) adenomas [5] and
demonstrates the whole colon, unlike FS. CTC also appears
attractive to invitees: A recent randomised trial found that
invitees anticipate the CTC procedure as being less painful
and embarrassing than OC [6]. A potential advantage of CTC
over OC and FS is that laxative components of the bowel
preparation can be reduced or even eliminated, decreasing
test burden [7]. Full-laxative bowel preparation is the most
inconvenient aspect of CTC [8, 9]. However, reducing or
eliminating the laxative component may diminish polyp
sensitivity and specificity (the probability of ruling out
disease when it is absent, avoiding false-positive results
and unnecessary follow-up investigations) [10] and qual-
itative research has suggested that screening invitees
prefer a more sensitive full-laxative bowel preparation,
despite greater burden [11]. However, a recent quantita-
tive study [12] found that the values placed on sensi-
tivity versus non-purgation were similar, with no overall
preference. It is therefore unclear whether non-laxative
CTC would be perceived as having sufficient accept-
ability to translate into higher uptake than full-laxative
CTC. Furthermore, CTC requires that patients undergo
the inconvenience of confirmatory follow-up testing if
polyps are suspected, whereas endoscopic tests can re-
move these during the same examination. This means it
is also unclear whether either form of CTC would be
perceived as having significant advantages and higher
uptake than endoscopic tests (particularly FS).
Most previous research [e.g. 13–16] has asked par-
ticipants to compare information on several tests and
state their overall preference. However, this differs sub-
stantially from real screening invitations [e.g. 17], which
typically contain information about a single test.
Another limitation is that study participants are rarely
provided with detailed information about the risks, costs
and benefits used in screening programmes to encourage
invitees to make an informed choice [18]. We aimed to
create a more realistic decision-making context by ran-
domly allocating individuals approaching screening age
to be sent detailed written information on a single CRC
screening test (non-laxative CTC, full-laxative CTC, FS
with enema bowel preparation or full-laxative OC). We
used a questionnaire survey to quantify how positively
or negatively individuals rated key aspects of each
screening test (e.g. tolerability of preparation and health
benefits) and compare ratings between tests. We also
measured and compared participants’ expectations of
how likely they were to participate in screening with
each test.
Materials and methods
Design
The research team sent out postal invitations to 13 primary
care centres (General Practices) that were identified by region-
al Primary Care Research Networks in England as being
potentially interested in participating in research. Of the seven
practices responding to the invitation, three were selected in
order to achieve a diverse mix of geographic and demographic
characteristics: two were located in Cumbria, a rural area with
an affluent, predominantly white British population; one was
in an urban area (London) with a heterogeneous socioeco-
nomic and ethnic population.
Following ethical approval, invitees were randomly
assigned to be mailed one of four study packs (in June 2013)
consisting principally of an information booklet and leaflet
(explaining screening and characteristics of one of the four
tests), a standardised questionnaire and a Freepost envelope.
Invitees were requested to read the booklet and leaflet, com-
plete the questionnaire and return it in the envelope.
Completion of the questionnaire constituted implied consent
to participate. Invitees who did not wish to participate were
requested to return the questionnaire blank and individuals
were sent reminder letters if they had not responded within
2 weeks of being contacted. Written materials are reproduced
in Appendices 1.1 to 1.4.
Participants
Eligible participants were all adults aged 45-54 years.
Exclusion criteria were (1) previous diagnosis of bowel can-
cer; (2) diagnosis of any cancer in the previous 6 months; (3)
learning disability; (4) receiving regular colonoscopies; (5)
experiencing significant cognitive decline; (6) clinically
judged to be unsuitable to participate in the study (e.g. due
to a terminal illness, mental health issue or inability to read
English). Electronic patient records were screened using da-
tabase queries and manual review by primary care practi-
tioners. After exclusions, a random sample of eligible partic-
ipants was selected at each practice in order to obtain an
approximately 2:1 ratio of Cumbria and London invitees for
a more nationally representative proportion of white British
invitees.
Test conditions
Participants were sent information regarding one of four tests:
non-laxative CTC, full-laxative CTC, FS and OC. This infor-
mation was designed using detailed literature from the English
Bowel Cancer Screening Programme (BCSP) as a template.
The BCSP provides invitees with written information on the
current standard screening method in England (guaiac faecal
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occult blood testing, followed by OC if the test is abnormal)
[19, 20] and these booklets provide a useful indication of the
material that would be required if any of the four tests in this
study were offered as part of a national screening programme.
Hence, study information materials were designed to be iden-
tical in style and wording to BCSP materials and were con-
sistent across test conditions wherever possible (see Fig. 1 for
an example). Key similarities and differences in the de-
scriptions for each test are described in Appendix 2. As an
example of a characteristic that differed between test
conditions, FS was described as reducing the risk of
getting bowel cancer by 23 % and dying from the disease
by 31 % [from 21]. Since tests that demonstrate the whole
colon confer greater theoretical benefit than a test of the
distal colon only, CTC and OC were described as being
estimated to reduce the respective risks by at least 23 %
and 31 %. Statistics were derived from existing literature
[20–34] and expert radiologist opinion. Drafts of study
materials were piloted using a “think-aloud” technique
[35] in which lay members of the public read through
each leaflet out loud and articulated what they were
thinking at various stages. This allowed text that was
difficult to understand to be identified and amended.
Outcomes
Participants were asked: “Imagine you have just received an
invitation to have the [test name] test in the post. Realistically
speaking, would you decide to have the [test name] test?”
Response options were “definitely not”, “probably not”, “yes,
probably” and “yes, definitely”. The primary outcome was
whether participants stated that they would “definitely” have
the test (participants responding with this option were
categorised as intenders; participants responding with any
other option were categorised as non-intenders). This question
was adapted from amulticentre randomised trial on efficacy of
FS, where there is evidence that responses are a strong pre-
dictor of subsequent screening behaviour [22, 36, 37].
Invitees were asked to rate their agreement with six state-
ments regarding their perceptions of the test itself (e.g. “hav-
ing the test would be embarrassing”). Response options
consisted of a 5-point Likert scale ranging from “strongly
Fig. 1 Example pages from an information leaflet (non-laxative CTC)
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disagree” to “strongly agree” and were scored 1-5 with higher
scores representing more positive perceptions. Cronbach’s α
(a measure of whether a set of items reliably measure the same
factor) was 0.72 for items relating to perceptions of the test,
indicating that the average correlation between scores on these
items was acceptably high. Consequently, scores for these six
items were summed for each participant to create an overall
test perception score. Invitees were also asked to rate how
strongly they agreed or disagreed with three items relating to
perceptions of health benefits (e.g. “having the test would
reduce my risk of getting bowel cancer”) and four items
relating to perceptions of the preparation (e.g. “preparing
before the test would be uncomfortable”). These items were
analysed separately (instead of being summed to create two
overall scores for each participant) due to low Cronbach’s α
that could not be improved by omitting variables (α=0.62 and
0.68, respectively). Finally, a 5-point response scale ranging
from “very unlikely” to “very likely” allowed participants to
rate their views on two items relating to sensitivity (“the test
finding bowel cancer if I have it” and “the test finding polyps
if I have any”; α=0.91 and so responses were summed to
create an overall sensitivity perception score for each partici-
pant) and one item that assessed views of specificity (“having
a follow-up test that shows there was no problem”). The
choice of items was influenced by previously used measures
of screening test benefits and barriers [38, 39]. The secondary
outcomes consisted of overall scores for test tolerability and
sensitivity along with scores for individual items on prepara-
tion, specificity and health benefits.
Participants were also asked to report whether they had
read the information materials (question adapted from [40])
and asked six multiple-choice questions to assess comprehen-
sion (e.g. “The test would be done: At a hospital/At home/At a
GP practice”) with one point given for each correct answer.
The questionnaire ended with questions on demographics
(e.g. ethnicity and markers of socioeconomic status), partici-
pants’ perceived risk status compared to others (from [41])
and self-rated health. An estimate of socioeconomic status
was derived using a previously used method [42] that com-
bined responses to questions on education, and vehicle and
home ownership (one point was given for each having no
formal qualifications, no vehicle ownership and living in
rented accommodation). Scores ranged from 0-3; higher
scores represented greater deprivation.
Sample size
A meta-analysis that pooled heterogeneous studies of
hospital-based screening tests and a trial of non-laxative
CTC found actual uptake to vary around 30 % for the four
tests [43, 44]. Assuming that intentions to be screened would
be 20 % higher to account for the gap between intentions and
behaviour [37], approximately 50 % would definitely intend
to take the test. Four hundred four participants were estimated
to be required per group in order to detect a difference of at
least 10 % between two tests (considered clinically meaning-
ful;α=0.05,β=0.2) in an analysis of valid responders. A total
of 3,100 individuals were invited, anticipating a response rate
of approximately 50 %.
Randomisation sequence generation
A member of the research team carried out randomisation at
each individual practice in a single step, i.e. the allocation
sequence was not available to practice staff or the researchers
until all invitees had been allocated. All eligible individuals
living at a given address were allocated to the same condition.
A random value was assigned to each eligible household using
the rand() function in Excel (Excel 2010 for Windows,
Microsoft, Redmond, WA, USA). Values for all invitees were
then categorised into quartiles with each quartile representing
one test condition (conditions applied to each quartile were
determined through coin tosses prior to data collection).
Statistical analysis
Frequencies and percentages were used to illustrate demo-
graphic and other background data. All inferential analyses
used non-parametric methods (i.e. Kruskal-Wallis or Mann-
Whitney U tests to compare ordinal data and Pearson χ2 tests
to compare proportions) since Kolmogorov-Smirnov tests
indicated that relevant data were non-normal (p<0.05).
Pearson χ2 tests were used to compare the proportion of
intenders between tests. The first analysis compared valid
responders who had completed the study per the protocol
(i.e. they did not report being outside the eligible age range
for the study, had received the correct study pack, stated that
they had read the information in full and had answered the
question on intention to be screened). Sensitivity analyses
compared intentions between tests after re-categorising in-
tenders as those who responded with either “yes, definitely”
or “yes, probably”. Both analyses were then repeated in an
expanded analysis of all invitees (i.e. irrespective of whether
they had responded or not, whether study packs were unde-
livered or whether they met other criteria for the main analy-
sis). It was assumed that non-responders to the question on
intention would not have the test (or could not intend if the
study pack was returned undelivered). Wilson score 95 %
confidence intervals were calculated for each test individually
and across all tests.
Scores on items relating to perceptions were compared
using Kruskal-Wallis tests, followed by planned post-hoc
Mann-Whitney U tests to compare scores for which there
was strong evidence against the null hypothesis (p<0.05).
Missing data for items relating to perceptions were imputed
using multiple imputation [45]. Results did not differ
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meaningfully between imputed and non-imputed analyses so
only non-imputed statistics are shown for post-hoc compari-
sons. All analyses were carried out using SPSS 21 for
Windows (IBM, Armonk, NY).
Results
Flow of participants through the study is shown in
Appendix 3. Of 3,100 invitees, 1,468 were female (47.4 %)
with a median age of 49 years [interquartile range (IQR): 47 to
52]. Among 3,094 invitees with Index of Multiple
Deprivation (IMD) data, the median score was 13.4, and out
of 2,030 participants with ethnicity data (either self-reported
or from practice records), the majority were white British (n=
1,420; 70.0 %).
The response rate for valid responders was 19.5 % (26.0 %
in Cumbria and 7.5 % in London). Demographic characteris-
tics of valid responders are shown in Table 1. The median age
of valid responders was 50 years (IQR: 47 to 52). Themajority
of participants correctly answered at least five out of the six
comprehension questions (n=498; 81.4 %). Scores varied by
test; OC responders had higher scores (median: 6; IQR: 5 to 6)
than FS responders (5; 4 to 6), non-laxative CTC (5; 5 to 6)
and full-laxative CTC responders [5; 5 to 6; all p-values<
0.0005; effect sizes (r): 0.26 to 0.37]. Non-laxative CTC
responders also had higher scores than FS responders (p=
0.014; effect size: 0.14).
Survey responders were older than non-responders
(median age: 50 vs. 49 years) and resided in less deprived
areas (median IMD score: 11.5 vs. 14.4). Females were
more likely to be responders (25.8 %) than males
(18.8 %) and white British invitees were more likely to
respond than other ethnicities (40.4 % vs. 13.4 %; all p-
values<0.0005).
Intentions
Out of 603 valid responders (those who received the correct
study pack, read all information and responded to the intention
question), 288 indicated they would definitely have the test
(47.8 %). There was no strong evidence to suggest that the
proportion of intenders differed between tests (Table 2; χ2[3,
603]=4.49; p=0.213). The results of the three sensitivity
analyses were not meaningfully different (p-values ranged
from 0.408 to 0.917).
Perceptions of tests for valid responders
Kruskal-Wallis tests comparing perceptions between tests
showed strong evidence against the null hypothesis for all
four items relating to preparation, indicating that there were
differences between at least two test conditions (all p-values≤
0.001). There were also differences in terms of perceptions of
test tolerability (p<0.0005). There were no apparent differ-
ences for perceptions of sensitivity (p=0.310 to 0.535) or
specificity (p=0.250 to 0.576). Finally, there was no strong
evidence of differences for items relating to benefits, i.e.
whether the test would reduce the risk of developing bowel
cancer (p=0.290 to 0.476), dying from bowel cancer (p=
0.805 to 0.901) or dying in the next 10 years (p=0.460 to
0.621).
Planned post-hoc Mann-Whitney U tests between pairs of
test conditions on items relating to preparation showed strong
evidence of differences for most comparisons: Non-laxative
preparation for CTC was rated more positively than all other
methods in terms of avoiding discomfort and embarrassment.
It was also superior to full-laxative preparation for CTC and
OC in terms of ease of completion. In addition, preparation for
FS was rated more positively than full-laxative preparation for
CTC in terms of time manageability and avoiding discomfort.
Finally, preparations for all tests were rated more positively
compared to full-laxative OC in terms of time manageability,
avoiding discomfort and ease of completion. These results
created a ranking in which non-laxative CTC preparation
was rated more positively overall compared to enema prepa-
ration for FS, which was rated more positively than full-
laxative CTC preparation, followed by full-laxative OC prep-
aration. In terms of the tests themselves, all were perceived
more positively than OC. Table 3 shows results of all post-hoc
comparisons andmedian overall scores for test tolerability and
individual items relating to preparation. Appendix 4 shows
median scores and IQRs of items for which there was weak
evidence against the null hypothesis.
Discussion
In this study, people were given standardised information
regarding different screening tests to a level of detail consis-
tent with material provided by the English Bowel Cancer
Screening Programme. The study was strengthened by using
the pre-existing information leaflet as a template since it had
been designed with the aim of facilitating an evaluation of the
risks, costs and benefits of screening participation. A further
strength was the randomised design, which meant that groups
were comparable and that intentions were derived in a setting
more closely matching a genuine screening invitation.
We found a clear order of perceived tolerability for prepa-
rations, consistent with previous studies showing reduced-
and non-laxative preparations are perceived as superior to
full-laxative methods regarding anticipated burden [6, 11,
12]. Our study adds to these findings by showing that non-
laxative preparations are also rated more positively than the
enema that precedes FS.We also found that all tests were rated
more positively than OC in terms of the anticipated experience
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of the procedures themselves. Previous research has shown
that CTC is considered more tolerable than OC for screening,
in terms of both patients’ expectations (e.g. [6]) and their
eventual experience [46]. Our study supports these findings
and also shows that participants did not rate CTC more pos-
itively than FS, surprisingly, since CTC does not require
invasive intubation to the same extent.
Despite differences in perceptions, we found no convincing
evidence that future screening intentions differed between
either form of CTC, or between CTC and endoscopic alterna-
tives. This was the case when the analysis focused only on
valid responders and when the analysis included non-
responders, even though the latter increased statistical power
and narrowed confidence intervals. In some respects, this
agrees with previous research: a meta-analysis [43] pooled
screening uptake for several of the tests under investigation
and found only a small difference between full-laxative CTC
and OC in favour of the latter (22 % vs. 28%, respectively; FS
had uptake of 35 %). However, data on non- and reduced-
laxative CTC were not included. A previous trial of screening
behaviour found that uptake of reduced-laxative CTC was
markedly higher compared with full-laxative OC (34 % vs.
22 %, respectively) [44]. As a result, it might be assumed that
reducing the laxative component of bowel preparation has a
Table 1 Demographic statistics
of all valid responders Non-laxative
CTC
Full-laxative
CTC
FS OC Total
N (%) N (%) N (%) N (%) N (%)
Gender
Male 71 (46.4) 66 (42.6) 64 (44.4) 61 (40.4) 262 (43.4)
Female 82 (53.6) 89 (57.4) 80 (55.6) 90 (59.6) 341 (56.6)
Employment status
Employed 131 (86.8) 129 (86.6) 130 (90.9) 132 (89.8) 522 (88.5)
Not employed/retired 19 (12.6) 19 (12.8) 13 (9.1) 13 (8.8) 64 (10.8)
Prefer not to say 1 (0.7) 1 (0.7) 0 (0.0) 2 (1.4) 4 (0.7)
Ethnicity
White British 132 (89.8) 132 (88.6) 126 (88.1) 135 (91.2) 525 (89.0)
Other 18 (10.2) 17 (11.4) 17 (11.9) 13 (8.8) 65 (11.0)
First language
English 140 (92.1) 139 (92.1) 136 (94.4) 140 (94.6) 555 (93.3)
Prefer not to state/other 12 (7.9) 12 (7.9) 8 (5.6) 8 (5.4) 40 (6.7)
Socioeconomic status score
0 (Least deprived) 55 (41.7) 55 (39.9) 58 (41.7) 57 (43.8) 225 (41.7)
1 70 (53.0) 76 (55.1) 75 (54.0) 63 (48.5) 284 (52.7)
2 6 (4.5) 6 (4.3) 6 (4.3) 8 (6.2) 26 (4.8)
3 (Most deprived) 1 (0.8) 1 (0.7) 0 (0.0) 2 (1.5) 4 (0.7)
Exposure to bowel cancer
Knows someone with CRC 86 (56.2) 80 (53.0) 82 (56.9) 73 (49.7) 321 (53.9)
Does not know someone with CRC 67 (43.8) 70 (46.4) 60 (41.7) 71 (48.3) 268 (45.0)
Prefer not to say 0 (0.0) 1 (0.7) 2 (1.4) 3 (2.0) 6 (1.0)
Previous experience with bowel tests
No previous bowel tests 126 (82.4) 124 (82.1) 126 (88.1) 129 (87.8) 505 (85.0)
One or more previous bowel tests 27 (17.6) 27 (17.9) 17 (11.9) 18 (12.2) 89 (15.0)
Self-rated health
Excellent 28 (18.5) 35 (23.3) 33 (22.9) 39 (26.4) 132 (22.4)
Good 92 (60.9) 84 (56.0) 83 (57.6) 77 (52.0) 336 (56.9)
Fair 27 (17.9) 30 (20.0) 28 (19.4) 30 (20.3) 115 (19.5)
Poor 4 (2.6) 1 (0.7) 0 (0.0) 2 (1.4) 7 (1.2)
Perceived risk of dying from CRC (compared to same age/gender)
Below average/much below average 36 (24.3) 38 (25.8) 29 (20.4) 30 (21.1) 133 (23)
Average 95 (64.2) 90 (61.2) 102 (71.8) 98 (69.0) 385 (66.5)
Above average/much above average 17 (11.5) 19 (12.9) 11 (7.7) 14 (9.9) 61 (10.5)
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Table 2 Number and percentage of intenders and non-intenders, overall and for each test
Sample size Intenders Number (%) responding for other options
“Yes, definitely”
N (%)
95 % CI “Yes, probably” “Probably not” “Definitely not” No response
(non-intenders)
All valid responders
Overall 603 288 (47.8) 43.8 to 51.7 % 262 (43.4) 45 (7.5) 8 (1.3) N/A
Non-laxative CTC 144 74 (51.4) 43.3 to 59.4 % 56 (38.9) 11 (7.6) 3 (2.1) N/A
Full-laxative CTC 153 76 (49.7) 41.9 to 57.5 % 65 (42.5) 11 (7.2) 1 (0.7) N/A
Flexible sigmoidoscopy 155 77 (49.7) 41.9 to 57.5 % 67 (43.2) 10 (6.5) 1 (0.6) N/A
Colonoscopy 151 61 (40.4) 32.9 to 48.4 % 74 (49.0) 13 (8.6) 3 (2.0) N/A
All invitees
Overall 3100 323 (10.4) 9.4 to 11.5 % 291 (9.4) 52 (1.7) 11 (0.4) 2423 (78.2)
Non-laxative CTC 765 83 (10.8) 8.8 to 13.3 % 66 (8.6) 11 (1.4) 4 (0.5) 601 (78.6)
Full-laxative CTC 763 83 (10.9) 8.9 to 13.3 % 72 (9.4) 12 (1.6) 2 (0.3) 594 (77.9)
Flexible sigmoidoscopy 780 87 (11.2) 9.1 to 13.6 % 71 (9.1) 12 (1.5) 1 (0.1) 609 (78.1)
Colonoscopy 792 70 (8.8) 7.1 to 11.0 % 82 (10.4) 17 (2.1) 4 (0.5) 619 (78.2)
Table 3 Mann-Whitney U test results comparing preparation and test tolerability items between tests (left)
Full-laxative CTC Flexible sigmoidoscopy Colonoscopy Median score
p-value (effect size) p-value (effect size) p-value (effect size) (IQR)
Preparation
Time manageability
Non-laxative CTC 0.091 (0.10) 0.159 (0.08) <0.0005 (0.22) 4 (4-4.75)
Full-laxative CTC 0.002 (0.17) 0.036 (0.12) 4 (3-4)
Flexible sigmoidoscopy <0.0005 (0.29) 4 (4-5)
Colonoscopy 4 (3-4)
Avoiding discomfort
Non-laxative CTC <0.0005 (0.43) <0.0005 (0.27) <0.0005 (0.54) 4 (3-4)
Full-laxative CTC 0.004 (0.16) 0.007 (0.16) 3 (2-4)
Flexible sigmoidoscopy <0.0005 (0.34) 3 (2-4)
Colonoscopy 2 (2-3)
Avoiding embarrassment
Non-laxative CTC 0.001 (0.19) 0.015 (0.14) <0.0005 (0.23) 4 (4-4)
Full-laxative CTC 0.614 (0.03) 0.278 (0.06) 4 (3-4)
Flexible sigmoidoscopy 0.130 (0.09) 4 (3-4)
Colonoscopy 4 (2.25-4)
Ease of completion
Non-laxative CTC 0.030 (0.13) 0.743 (0.02) <0.0005 (0.25) 4 (3-4)
Full-laxative CTC 0.070 (0.10) 0.027 (0.13) 4 (3-4)
Flexible sigmoidoscopy <0.0005 (0.22) 4 (3-4)
Colonoscopy 3 (2-4)
Test tolerability
Non-laxative CTC 0.825 (0.01) 0.687 (0.02) <0.0005 (0.28) 18 (15-20)
Full-laxative CTC 0.562 (0.03) <0.0005 (0.26) 17 (15-20)
Flexible sigmoidoscopy <0.0005 (0.27) 18 (15-21)
Colonoscopy 15 (13-18)
Median acceptability scores in each test condition (right); P-values less than 0.05 are in bold; effect size (r)=Z/√N
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large effect on uptake but this is uncertain without a direct
comparison of CTC uptake following different preparations.
Our findings suggest that there would be little difference
between methods.
Although correlation between intention and behaviour is
well established [37, 47], it is possible that differences in
uptake would only become apparent following a genuine
screening invitation instead of a hypothetical one. Perceived
differences in preparation and test tolerability may become
more influential following a real invitation: The prospect of
discomfort and inconvenience may be more immediate,
whereas potential health gains remain in the relatively distant
future [48]. Hence, a randomised trial would be the most valid
method to compare actual uptake of different forms of CTC
and other tests. It could also be argued that improving per-
ceived tolerability is desirable on the grounds of improving
patient satisfaction, even if uptake does not improve. In this
respect, our results favour non-laxative CTC over all other
modalities in terms of participants’ perceptions of the test
(compared to OC) and the preparation (compared to all
alternatives).
It was surprising that there were no apparent differences
between tests in terms of perceived sensitivity and specificity,
despite large differences in the statistics provided. For exam-
ple, OC did not refer to false positives (since confirmatory
testing and polypectomy are generally not required) and FS
was described as having sensitivity of 65 % compared with
85-90 % for CTC and OC. Although we adapted a pre-
existing and rigorously designed leaflet as a template, it is
possible that participants were not able to use it to extract this
specific information and therefore may have had unrealistical-
ly positive views about FS (e.g. if they did not appreciate the
implications of FS only examining the distal third of the large
bowel). This may also reflect general weaknesses in partici-
pants’ health literacy or numeracy [49]. Future research may
assess whether current information can be improved in this
respect.
Our study has limitations. The response rate was lower than
anticipated and responders differed to non-responders regard-
ing several demographic characteristics. It is therefore possi-
ble that intentions and perceptions cannot be generalised for
all people approaching screening age. There is no evidence
that non-response bias differed by condition, but it is possible
that non-responders were more sensitive to the test on offer
compared to responders and would therefore have been more
likely to endorse some tests over others. It was also necessary
to create original items to measure perceptions since no vali-
dated alternatives existed. Although items were based on
existing questionnaires, Cronbach’s αwas too low to generate
reliable overall perception scales for preparation, health ben-
efits or accuracy. This resulted in numerous hypotheses being
tested but most p-values were very low or very high, reducing
the likelihood of incorrect inferences.
In conclusion, we found that perceptions of non-laxative
preparation for CTC are more positive compared to all alter-
natives and that the anticipated test experience of full- and
non-laxative CTC (and FS) is perceived as superior to OC.
However, we found no strong evidence that participants
are more likely to undergo either form of CTC com-
pared to alternatives. This suggests that uptake is un-
likely to be increased significantly by offering one test
over another.
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